ArticleBMC pregnancy and childbirth2026
Prenatal diagnosis and molecular cytogenetic analysis of Xp22.31 microdeletions and microduplications in Chinese populations.
Article in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundChromosome rearrangements are frequently observed in the Xp22.31 region. Xp22.31 microdeletion is linked to X-linked ichthyosis, whereas the pathogenicity of Xp22.31 microduplication remains a subject of controversy. In the present study, 52 additional foetuses with Xp22.31 microdeletions/microduplications were presented, with the aim of providing further insights into the prenatal diagnosis and genetic counselling of Xp22.31 microdeletions/microduplications.
methodsA retrospective analysis was conducted involving a total of 4,251 pregnant women who received amniocentesis of prenatal diagnosis in our hospital from January 2017 to August 2022. All of the subjects were subjected to karyotype and chromosomal microarray analysis (CMA) for evaluation of chromosomal abnormalities. Whole exome sequencing (WES) was subsequently employed to explore additional variants in individuals presenting unexplained clinical features.
resultsAmong the enrolled subjects, a total of 52 cases with Xp22.31 microdeletions/microduplications were detected using CMA, with a detection rate of 1.22% (52/4251). A total of 35 foetuses carried Xp22.31 microduplications and most of them exhibited normal developmental milestone after birth, except one case with motor and speech developmental delay. Additionally, 17 foetuses harbored Xp22.31 microdeletions, 10 male foetuses exhibited ichthyosis after birth, 6 female foetuses manifested normal clinical features, and the remaining were terminated based on parental request. In the present study, WES was further conducted on a foetus with renal abnormalities; however, no likely pathogenic or pathogenic variants in genes related to the observed phenotype were identified.
conclusionsThe present authors propose that Xp22.31 microduplication may be a benign copy number variant. In addition, the findings reveal, for the first time, a previously unknown association between renal agenesis and Xp22.31 microdeletion, thus expanding the range of clinical manifestations associated with Xp22.31 microdeletions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.